AXIM BIOTECHNOLOGIES, INC. Finite-Lived Intangible Asset, Expected Amortization, Year One
AXIM BIOTECHNOLOGIES, INC. (AXIM) had Finite-Lived Intangible Asset, Expected Amortization, Year One of $197.22 thousand as of 2024-06-30, per its 10-Q filed 2024-08-19.
Discontinued › Notes › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity
us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths · last filed 2024-08-19
- 2024-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year One $197.22K.
- 2024-03-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $292.62K.
- 2023-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $391.23K.
- 2022-12-31: Finite-Lived Intangible Asset, Expected Amortization, Year One $97.41K; Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed $391.23K.
| Period end | Finite-Lived Intangible Asset, Expected Amortization, Year One | Finite-Lived Intangible Asset, Expected Amortization, Year One as first filed |
|---|---|---|
| 2024-06-30 | $197.22K 10-Q · filed 2024-08-19 | |
| 2024-03-31 | $292.62K 10-Q/A · filed 2024-05-22 | |
| 2023-12-31 | $391.23K 10-K · filed 2024-04-16 | |
| 2022-12-31 | $97.41K 10-Q · filed 2023-11-20 | $391.23K 10-K · filed 2023-04-17 |
| 2022-09-30 | $98.66K 10-Q/A · filed 2022-11-15 | |
| 2022-06-30 | $197.23K 10-Q · filed 2022-08-16 | |
| 2022-03-31 | $295.84K 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $375.50K 10-K/A · filed 2022-04-19 | |
| 2021-09-30 | $2.09M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $1.95M 10-Q · filed 2021-08-23 |